MedTrace Logo

Plethismographic Perfusion Index in Neonates

NCT02380040 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2016-09-07

No results posted yet for this study

Summary

Photoplethismography will be measured and compared in newborns suffering from patent ductus arteriosus and normal controls.

Conditions

  • Patent Ductus Arteriosus
  • Persistent Pulmonary Hypertension of the Newborn

Interventions

DEVICE

PPG

A PPG device will be applied to subjects in the right hand, left hand and one of the legs. Data will be recorded into a computer software

Sponsors & Collaborators

  • Shaare Zedek Medical Center

    lead OTHER

Principal Investigators

  • Ruben Bromiker, MD · Shaare Zedek Medical Center, Jerusalem, Israel

Eligibility

Max Age
3 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2016-11-30
Completion
2017-03-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02380040 on ClinicalTrials.gov